Clinical Trial Update: Trastuzumab & Pertuzumab Followed by T-DM1 in MBC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring trastuzumab and pertuzumab followed by T-DM1 in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pertuzumab (pertuzumab)
• T-DM1 (ado-trastuzumab emtansine)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED